Breaking News Instant updates and real-time market news.

PANW

Palo Alto Networks

$201.76

-7.73 (-3.69%)

, FTNT

Fortinet

$81.80

1.63 (2.03%)

11:25
10/16/18
10/16
11:25
10/16/18
11:25

FBN Securities tech/software analysts to hold group luncheon

Analysts hold a Group Luncheon with a Key Security Reseller who is a Regional Manager responsible for sales of soltware solutions with a substantial focus on cybersecurity and associated services will be held in New York on October 16 hosted by FBN Securities.

PANW

Palo Alto Networks

$201.76

-7.73 (-3.69%)

FTNT

Fortinet

$81.80

1.63 (2.03%)

PFPT

Proofpoint

$104.88

3.82 (3.78%)

CHKP

Check Point

$113.30

2.18 (1.96%)

SAIL

SailPoint

$27.79

0.74 (2.74%)

VMW

VMware

$147.16

3.03 (2.10%)

JNPR

Juniper

$28.08

0.3 (1.08%)

TMICY

Trend Micro

$0.00

(0.00%)

  • 16

    Oct

  • 17

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 01

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 09

    Nov

  • 13

    Nov

  • 06

    Dec

  • 10

    Dec

PANW Palo Alto Networks
$201.76

-7.73 (-3.69%)

10/03/18
10/03/18
UPGRADE

Palo Alto Networks upgraded to Neutral from Best Idea Short at Arete
10/08/18
MSCO
10/08/18
NO CHANGE
MSCO
Palo Alto Networks, Fortinet price targets raised after checks at Morgan Stanley
Morgan Stanley analysts Melissa Franchi, Keith Weiss and James Faucette said their channel checks and reseller survey data support generally solid results from firewall vendors continuing into the second half of 2018 and strengthening in 2019, adding that Palo Alto Networks (PANW) remains the clear share gainer in the space. Talks also suggest the refresh activity around physical appliances remains healthy, added the analysts, who raised their price targets on Palo Alto to $276 from $262 and on Fortinet (FTNT) to $88 from $67. The firm keeps Palo Alto as its top pick in software security.
10/11/18
JPMS
10/11/18
NO CHANGE
JPMS
JPMorgan lists stand outs in Software Technology following recent selloff
The recent pullback in Software Technology stocks has not discriminated in terms of valuation, JPMorgan analyst Sterling Auty tells investors in a research note titled "Our Expected Pullback Finally Arrives." The analyst says he's seen similar selloffs in both his highest valuation stocks and even his lowest. Auty recommends "only nibbling" here and waiting for the next three to five trading sessions to see if it posts any big down days like we saw yesterday "to flush out any remaining volatility." Investors should not try to bottom pick stocks, but rather average into positions to smooth out some of the volatility, the analyst recommends. He views Adobe (ADBE), Ansys (ANSS), Aspen Technology (AZPN), DocuSign (DOCU), Guidewire (GWRE), Intuit (INTU), ServiceNow (NOW), Q2 Holdings (QTWO), Palo Alto Networks (PANW), VeriSign (VRSN) and Veeva (VEEV) as stand outs in Software Technology following the recent pullback.
10/15/18
JPMS
10/15/18
NO CHANGE
JPMS
Overweight
Palo Alto Networks' new director should impress investors, says JPMorgan
JPMorgan analyst Sterling Auty kept his Overweight rating on Palo Alto Networks, saying the company's appointment of Amit Singh as new President should "impress" investors as the "caliber" of people that the company is attracting under new CEO Arora remains high. Auty notes that while some may be concerned about the "pace of change in management", Palo Alto Networks' strategy of focusing on cloud security is "clear".
FTNT Fortinet
$81.80

1.63 (2.03%)

09/20/18
09/20/18
DOWNGRADE
Target $95

Neutral
Fortinet downgraded to Neutral from Buy at BofA/Merrill
As previously reported, BofA/Merrill downgraded Fortinet to Neutral from Buy primarily due to valuation and raised its price target to $95 from $78 on market strength.
09/26/18
OPCO
09/26/18
NO CHANGE
Target $97
OPCO
Outperform
Fortinet price target raised to $97 from $82 at Oppenheimer
Oppenheimer analyst Shaul Eyal raised his price target for Fortinet to $97 from $82, while reiterating an Outperform rating on the shares. With less than a week remaining in the quarter, Fortinet's momentum is exhibiting no signs of slowing down from its strong 1H18, he contends. The analyst believes continued outperformance could further expand its valuation multiple.
09/27/18
CLVD
09/27/18
NO CHANGE
CLVD
Buy
Fortinet estimates raised on favorable demand at Cleveland Research
Cleveland Research analyst Ben Bollin raised Fortinet estimates to reflect favorable underlying business momentum as seen by expansion in the number of partners, increased investment by existing partners, and increased customer visibility. The analyst raised his FY18 growth estimate by 100bps to +20.1% versus consensus of +19.1%, and views FY19 consensus view of +14% as conservative. Bollin has a Buy rating on Fortinet shares.
PFPT Proofpoint
$104.88

3.82 (3.78%)

09/21/18
WEDB
09/21/18
NO CHANGE
Target $136
WEDB
Outperform
Proofpoint shares have bottomed, 'headed north' again, says Wedbush
Wedbush analyst Steve Koenig tells investors in a research note that, after receiving questions about what's behind Proofpoint's poor price action, he has a "strong suspicion" that shares have bottomed and are headed north again. Koeing, who has an Outperform rating and $136 price target on shares, says he sees growing recognition among shareholders that out-year consensus revenues are too high and valuation looks compelling.
09/26/18
SUSQ
09/26/18
NO CHANGE
Target $138
SUSQ
Positive
Proofpoint checks point to solid Q3 results, says Susquehanna
Susquehanna analyst Anne Meisner said her preliminary channel checks on Proofpoint suggest a modest upside to second half estimates. She also said the recent weakness in the shares is a buying opportunity as the conservative out-year growth guidance is well understood by investors. The analyst lowered her estimates, but she expects the company to achieve her prior estimates. Meisner reiterated her Positive rating and $138 price target on Proofpoint shares.
10/01/18
DBAB
10/01/18
NO CHANGE
Target $125
DBAB
Buy
Proofpoint price target lowered to $125 from $140 at Deutsche Bank
Deutsche Bank analyst Gray Powell lowered his price target for Proofpoint to $125 saying channel checks left him "slightly more cautious" on the company and the email security space. On the positive side, contacts generally indicated that demand was at or above expectations, Powell tells investors in a research note. However, the analyst also picked up data points suggesting an uptick in competition, a slightly higher pace of discounting, and expectations for a moderation in growth in 2019. He sees some "yellow" flags following the checks but keeps a Buy rating on Proofpoint.
10/12/18
EVER
10/12/18
NO CHANGE
Target $135
EVER
Outperform
Evercore adds Proofpoint to Core Ideas List after 'overdone' selloff
Evercore ISI analyst Ken Talanian views the recent pullback in shares of Proofpoint as overdone and added the stock to his firm's SMID Core Ideas List. Proofpoint offers investors a "unique opportunity to participate in a high-quality subscription growth story that benefits from the broader move to the cloud," Talanian tells investors in a research note. He sees an attractive entry point after the 25% selloff from the July highs and keeps an Outperform rating on the name with a $135 price target.
CHKP Check Point
$113.30

2.18 (1.96%)

07/31/18
SBSH
07/31/18
NO CHANGE
SBSH
Neutral
Citi places 'Negative Catalyst Watch' on Check Point Software
Citi analyst Walter Pritchard put Check Point Software on his firm's "Negative Catalyst Watch" list citing concerns about disruption to its sales organization. The analyst believes the company's new sales leadership could face turnover in sales and increase concern about risk to Q3 and Q4 estimates. Pritchard keeps a Neutral rating on Check Point shares.
09/07/18
PIPR
09/07/18
NO CHANGE
Target $250
PIPR
Overweight
Palo Alto Networks price target raised to $250 from $230 at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski raised his price target for Palo Alto Networks (PANW) to $250 saying the company last night reported strong Q4 results, exceeding the high-end of guidance by 3.6%. The analyst believes Palo Alto continues to "leverage the power of the platform," taking market share from both Cisco Systems (CSCO) and Check Point (CHKP). Nowinski thinks Palo Alto "still has a significant opportunity" for further share gains and he keeps an Overweight rating on the name.
10/12/18
OTRG
10/12/18
DOWNGRADE
OTRG
Mixed
Check Point downgraded to Mixed from Positive at OTR Global
07/31/18
JPMS
07/31/18
NO CHANGE
JPMS
Neutral
Check Point change in sales leadership an incremental negative, says JPMorgan
After Checkpoint announced Dan Yerushalmi will be its new head of worldwide sales and strategy, replacing Pierre-Paul Allard, JPMorgan analyst Sterling Auty called the news of the change an incremental negative, noting that incoming sales leaders frequently make changes that require three quarters to start paying full benefits. Auty maintains his Neutral rating on Check Point shares.
SAIL SailPoint
$27.79

0.74 (2.74%)

08/09/18
OPCO
08/09/18
NO CHANGE
Target $35
OPCO
Outperform
SailPoint price target raised to $35 from $28 at Oppenheimer
Oppenheimer analyst Shaul Eyal raised his price target for SailPoint to $35 from $28 after the company reported "strong" Q2 results, exceeding Street's expectations and raising FY18 guidance. The analyst reiterates an Outperform rating on the shares.
08/21/18
GSCO
08/21/18
INITIATION
Target $32
GSCO
Neutral
SailPoint initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Gabriela Borges initiated SailPoint with a Neutral and $32 price target.
09/11/18
NORL
09/11/18
INITIATION
NORL
Market Perform
SailPoint initiated with a Market Perform at Northland
Northland analyst Tim Klasell initiated SailPoint with a Market Perform and $34 price target citing "stretched" valuation.
09/11/18
09/11/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Krystal Biotech (KRYS) initiated with an Overweight at Cantor Fitzgerald. 2. Melinta Therapeutics (MLNT) initiated with a Buy at H.C. Wainwright and Jefferies. 3. Burlington Stores (BURL) initiated with an Overweight at Barclays. 4. General Motors (GM) reinstated with a Neutral at Goldman Sachs. 5. SailPoint (SAIL) initiated with a Market Perform at Northland. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
VMW VMware
$147.16

3.03 (2.10%)

09/24/18
09/24/18
DOWNGRADE

Negative
Nutanix downgraded to Negative from Neutral at Susquehanna
As previously reported, Susquehanna analyst Mehdi Hosseini downgraded Nutanix to Negative from Neutral and reduced his price target on shares to $33 from $55. The analyst believes Nutanix's OEM relationships are likely to become "less impactful over time," and also cited increasing competition as a headwind. Hosseini specifically said not to count out Microsoft (MSFT), noted that VMware (VMW) continues to add new features for vSAN while tightening integration with AWS, and expects an IPO from Dell in the coming months.
09/18/18
WBLR
09/18/18
NO CHANGE
WBLR
Outperform
Fears of Google competition for Nutanix look overblown, says William Blair
Shares of Nutanix (NTNX) fell yesterday after The Information reported that Google (GOOG, GOOGL) is working on a potential hyperconverged infrastructure product that could conceptually compete with Nutanix, William Blair analyst Jason Ader tells investors in a research note titled "Fears of Google Entering HCI Space Look Overblown to Us". This is likely Google's response to what Microsoft (MSFT) has built with Azure Stack, which is Microsoft's HCI product that connects directly into its Azure public cloud service, Ader contends. He believes that if Google turn this into an actual packaged HCI product sold to a broad range of customers, it could create longer-term risk for Nutanix. However, thinks investors should consider that this appears to be another validation of the staying power of the on-premises market, which he says bodes well for Nutanix. Further, he points out that if Google were to decide to enter the HCI market more broadly, it would have a long way to go to establish itself in the enterprise against entrenched players like Nutanix and VMware (VMW). Google has not had great success selling into the enterprise historically and has little experience selling enterprise infrastructure appliances, Ader writes. The analyst reiterates an Outperform rating on Nutanix.
09/05/18
CLVD
09/05/18
NO CHANGE
CLVD
VMware estimate raised on positive partner feedback at Cleveland Research
Cleveland Research raised VMware FY20 estimates to reflect favorable partner feedback that indicates growth in the low double digits range into FY with increased contribution from bundling, VMC, and hybrid cloud adoption.
08/31/18
OPCO
08/31/18
NO CHANGE
Target $180
OPCO
Outperform
Oppenheimer adds VMware to top picks, ups price target to $180
Oppenheimer analyst Ittai Kidron raised his price target for VMware to $180 from $170 and added the shares to his firm's top picks. At the current valuation, the analyst believes there is still skepticism with respect to VMware's competitive positioning and ability to grow in the face of a cloud transition. However, his survey of VMware's customers indicate otherwise. Kidron left VMworld "incrementally positive" on VMWare's ability to execute on its any cloud/application/device strategy and drive further license growth. Further, his customer survey points to strong spending intentions and new product uptake ahead. The analyst stays bullish on VMware with an Outperform rating.
JNPR Juniper
$28.08

0.3 (1.08%)

09/26/18
UBSW
09/26/18
INITIATION
Target $31
UBSW
Neutral
Juniper initiated with a Neutral at UBS
UBS analyst John Roy started Juniper Networks with a Neutral rating and $31 price target. The analyst believes the company's "growth inflection" is at least a couple of years away.
09/19/18
09/19/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Transocean (RIG) upgraded to Outperform from Market Perform at Wells Fargo with analyst Judson Bailey saying he "significantly" increased his EBITDA and net asset value estimates across the offshore drilling space to reflect increasing demand combined with tightening availability for high spec ultra-deepwater rigs. 2. TSMC (TSM) upgraded to Overweight from Equal Weight at Morgan Stanley. 3. Mechel (MTL) upgraded to Neutral from Sell at Citi. 4. Juniper (JNPR) upgraded to Buy from Neutral at Nomura Instinet with analyst Jeffrey Kvaal saying he believes Juniper "will finally be able to catch the webscale capex growth tailwind in 2019." 5. E-Trade (ETFC) upgraded to Buy from Hold at Jefferies with analyst Daniel Fannon saying the stock's current valuation is attractive for the core business while the financial and strategic benefits as a takeout candidate remain intact. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/19/18
NOMU
09/19/18
UPGRADE
Target $34
NOMU
Buy
Nomura upgrades Juniper to Buy on routing recovery, other growth drives
Nomura Instinet analyst Jeffrey Kvaal upgraded Juniper Networks to Buy from Neutral and raised his price target for the shares to $34 from $28. The analyst believes Juniper "will finally be able to catch the webscale capex growth tailwind in 2019." He expects the company to recover from its webscale routing "annus horribilis," gain share in webscale switching, and continue its enterprise growth. Kvaal expects webscale capital expenditures to rise 40% in 2018 and he lifted his 2019 sales estimate for Juniper to 5%.
09/19/18
NOMU
09/19/18
UPGRADE
Target $34
NOMU
Buy
Juniper upgraded to Buy from Neutral at Nomura Instinet
Nomura Instinet analyst Jeffrey Kvaal upgraded Juniper Networks to Buy and raised his price target for the shares to $34 from $28.
TMICY Trend Micro
$0.00

(0.00%)

TODAY'S FREE FLY STORIES

SOR

Source Capital

$37.94

0.26 (0.69%)

17:02
11/12/18
11/12
17:02
11/12/18
17:02
Hot Stocks
Source Capital declares $3.20 per share special dividend »

Source Capital declared a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YRD

Yirendai

$15.47

-1.75 (-10.16%)

17:01
11/12/18
11/12
17:01
11/12/18
17:01
Earnings
Yirendai reports Q3 adjusted income per ADS 87c, consensus 52c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

LTM

Latam Airlines

$8.96

-0.39 (-4.17%)

17:00
11/12/18
11/12
17:00
11/12/18
17:00
Hot Stocks
Latam Airlines reports October passenger traffic up 1.5% »

LATAM Airlines Group …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ETON

Eton Pharmaceuticals

$0.00

(0.00%)

16:53
11/12/18
11/12
16:53
11/12/18
16:53
Syndicate
Eton Pharmaceuticals 3.6M share IPO priced at $6.00 »

National Securities acted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENR

Energizer

$60.18

-1.235 (-2.01%)

16:49
11/12/18
11/12
16:49
11/12/18
16:49
Hot Stocks
Energizer names Patrick Moore chairman of the board »

Energizer Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ACIU

AC Immune

$8.74

0.01 (0.11%)

16:47
11/12/18
11/12
16:47
11/12/18
16:47
Initiation
AC Immune initiated  »

AC Immune initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRNT

Kornit Digital

$19.15

-0.88 (-4.39%)

16:47
11/12/18
11/12
16:47
11/12/18
16:47
Earnings
Kornit Digital reports Q3 adjusted EPS 13c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ZGNX

Zogenix

$40.82

0.05 (0.12%)

16:46
11/12/18
11/12
16:46
11/12/18
16:46
Initiation
Zogenix initiated  »

Zogenix initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ADMS

Adamas Pharmaceuticals

$11.45

-0.455 (-3.82%)

16:45
11/12/18
11/12
16:45
11/12/18
16:45
Initiation
Adamas Pharmaceuticals initiated  »

Adamas Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 27

    Nov

  • 27

    Nov

AGN

Allergan

$163.82

-1.77 (-1.07%)

16:45
11/12/18
11/12
16:45
11/12/18
16:45
Initiation
Allergan initiated  »

Allergan initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

SAGE

Sage Therapeutics

$121.50

-9.46 (-7.22%)

16:45
11/12/18
11/12
16:45
11/12/18
16:45
Initiation
Sage Therapeutics initiated  »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 27

    Nov

  • 19

    Dec

NBIX

Neurocrine

$103.03

-2.18 (-2.07%)

16:44
11/12/18
11/12
16:44
11/12/18
16:44
Initiation
Neurocrine initiated  »

Neurocrine initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

HLUYY

Lundbeck

$0.00

(0.00%)

16:44
11/12/18
11/12
16:44
11/12/18
16:44
Initiation
Lundbeck initiated  »

Lundbeck initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWPH

GW Pharmaceuticals

$134.48

-3.3 (-2.40%)

16:43
11/12/18
11/12
16:43
11/12/18
16:43
Initiation
GW Pharmaceuticals initiated  »

GW Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

BHVN

Biohaven Pharmaceutical

$36.42

-2.47 (-6.35%)

16:42
11/12/18
11/12
16:42
11/12/18
16:42
Initiation
Biohaven Pharmaceutical initiated  »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

  • 27

    Nov

ACAD

Acadia

$18.86

-0.01 (-0.05%)

16:42
11/12/18
11/12
16:42
11/12/18
16:42
Initiation
Acadia initiated  »

Acadia initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ALKS

Alkermes

$34.70

-2.98 (-7.91%)

16:41
11/12/18
11/12
16:41
11/12/18
16:41
Initiation
Alkermes initiated  »

Alkermes initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

  • 31

    Jan

GATX

GATX

$76.43

-2.54 (-3.22%)

16:37
11/12/18
11/12
16:37
11/12/18
16:37
Hot Stocks
GATX acquires up to 3,100 railcars for $229M »

GATX Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVGS

Navigator Holdings

$12.03

-0.13 (-1.07%)

16:35
11/12/18
11/12
16:35
11/12/18
16:35
Earnings
Navigator Holdings reports Q3 EPS 1c, consensus (2c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

GRA

W.R. Grace

$63.83

-0.705 (-1.09%)

16:35
11/12/18
11/12
16:35
11/12/18
16:35
Hot Stocks
W.R. Grace to increase price for silica-based, molecular sieve products by 7% »

W. R. Grace will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQH

AXA Equitable

$21.09

-0.355 (-1.66%)

16:34
11/12/18
11/12
16:34
11/12/18
16:34
Hot Stocks
AXA Equitable reports Q3 annualized premiums up 2% »

Reports Q3 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

EQH

AXA Equitable

$21.09

-0.355 (-1.66%)

16:33
11/12/18
11/12
16:33
11/12/18
16:33
Hot Stocks
Breaking Hot Stocks news story on AXA Equitable »

AXA Equitable announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

EQH

AXA Equitable

$21.09

-0.355 (-1.66%)

16:32
11/12/18
11/12
16:32
11/12/18
16:32
Earnings
AXA Equitable reports Q3 adjusted EPS $1.23, consensus 91c »

Reports Q3 revenue $1.08B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

HAL

Halliburton

$34.17

-0.81 (-2.32%)

16:31
11/12/18
11/12
16:31
11/12/18
16:31
Hot Stocks
Halliburton names Lance Loeffler as CFO, Chris Weber to leave company »

Halliburton is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELVT

Elevate Credit

$4.11

-0.08 (-1.91%)

16:31
11/12/18
11/12
16:31
11/12/18
16:31
Hot Stocks
Elevate Credit appoints David Peterson Chief Credit Officer »

Elevate Credit announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.